1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL BIOPHOTONICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Imaging Technologies
5.3. Spectroscopy Technologies
5.4. Light-Based Therapeutics
5.5. Biosensors and Bioassays
6. GLOBAL BIOPHOTONICS MARKET BY APPLICATION
6.1. Introduction
6.2. Medical Diagnostics
6.3. Therapeutics
6.4. Research and Development
6.5. Environmental Monitoring
7. GLOBAL BIOPHOTONICS MARKET BY END-USERS
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Research Institutions and Laboratories
7.4. Pharmaceutical and Biotechnology Companies
7.5. Environmental Agencies
8. GLOBAL BIOPHOTONICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. Becton, Dickinson and Company
10.3. Carl Zeiss AG
10.4. Hamamatsu Photonics K.K.
10.5. Olympus Corporation
10.6. PerkinElmer Inc.
10.7. Bruker Corporation
10.8. Danaher Corporation
10.9. Oxford Instruments Plc
10.10. Lumenis Be Ltd.
10.11. IPG Photonics Corporation
10.12. Nikon Corporation
10.13. Bio-Rad Laboratories, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES